SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Art Pappas will speak about future trends in biotechnology at the Charlotte Biotechnology Conference in Charlotte, NC
News | 10. 27. 2010
